In a notable transaction, Syntone Ventures LLC, a ten percent owner of Outlook Therapeutics, Inc. (NASDAQ:OTLK), has made a substantial purchase of the company's shares. The transaction ...

Nacubactam is under clinical development by NacuGen Therapeutics and currently in Phase III for Pyelonephritis. According to GlobalData, Phase III drugs for Pyelonephritis have an 89% phase transition ...

According to Market.Us, the size of the Gout Therapeutics Market is projected to reach approximately USD 5.4 Billion by 2032, up from USD 2.4 Billion in 2022. This growth represents a compound annual ...

The average one-year price target for Enliven Therapeutics (NasdaqGS:ELVN) has been revised to 35.02 / share. This is an increase of 10.75% from the prior estimate of 31.62 dated March 28 ...

On Tuesday, Oppenheimer raised its rating on Avalo Therapeutics Inc. (NASDAQ: NASDAQ:AVTX) stock from Perform to Outperform, setting a price target of $35.00. The upgrade follows Avalo Therapeutics' ...

On Tuesday, Oppenheimer raised its rating on Avalo Therapeutics Inc. (NASDAQ: NASDAQ:AVTX) stock from Perform to Outperform, setting a price target of $35.00. The upgrade follows Avalo ...

SAN MATEO, Calif. - CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company, announced today the appointment of Dr. Kapil Dhingra to its Board of Directors. Dr. Dhingra, a ...

Swayman will tend the twine on the road against Washington on Monday, Stephen Whyno of the Associated Press reports. Swayman will try to bounce back from a disappointing loss to the Hurricanes ...

Keros Therapeutics' estimated fair value is US$93.42 based on 2 Stage Free Cash Flow to Equity Current share price of US$58.61 suggests Keros Therapeutics is potentially 37% undervalued The US$88. ...

SEATTLE — Chicago Cubs closer Adbert Alzolay was confident the replay review would vindicate him. Alzolay’s perfectly-timed pickoff move with two outs in the bottom of the ninth inning Sunday ...

Given the plans announced by private players and participants, investments of around $180-$200 billion are expected in the green hydrogen space in India in the run-up to 2030. The projected 5 ...